You are here

Cigna First Private Insurer to Consider Exoskeleton Device Coverage

Policy Could Be Life-Changing for People With Spinal Cord Injury

Cigna Corporation has revised its policy on coverage of exoskeleton medical devices for people with spinal cord injury (SCI). Previously, the insurer had a non-coverage policy, but they now plan to review submissions on a case-by-case basis. The policy change is already in effect.

The policy revision is the first of its kind by any major private insurer for people who are eligible for exoskeleton devices. However, in 2015, the Department of Veterans Affairs set out a national policy for the evaluation, training in, and procurement of ReWalk’s Personal exoskeleton systems for all qualifying veterans in the U.S.

According to the National Spinal Cord Injury Statistical Center, there are approximately 17,700 new SCI cases each year. The current number of people with SCI in the U.S. is estimated at 288,000.

ReWalk Robotics Ltd., whose U.S. location is in Massachusetts, develops and manufactures wearable robotic exoskeletons for individuals with lower limb disabilities resulting from spinal cord injury or stroke.

Source: ReWalk Robotics, Ltd., February 13, 2019

Recent Headlines

Averts Disease Worsening, Reduces Potential for Blindness
Risk May Remain for 6 Months After Treatment
FDA Removes Boxed Warning With Drug’s Fifth Approval
Overeager Use of Recommendations Creates Problems
Artificial Intelligence Enables Platform to Detect Amyloid PET Status
Kadcyla Cut Risk of Recurring Disease by Half Compared to Herceptin
May Lead to Personalized Treatment for Schizophrenia, Other Illnesses
Rare Disorder Typically Co-occurs With Cancer